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1378. The Norwood procedure has undergone numerous modifications sinceits original description.1 The term “modified” Norwood now appliesto several variations both in the reconstructive techniques and in theconduct of bypass.2,3 Surgeons now have available technical modi-fications that can be applied to the variable anatomy encounteredwithin the complex spectrum of hypoplastic left heart syndrome. Of
equal importance to the technical advances, better understanding of the Norwood
physiology and improved postoperative management have resulted in improved
outcomes.4-6 In fact, it is difficult to separate the technical aspects from the
physiologic as, more than in any other lesion, the two are interdependent.
Perhaps one of the most critical observations made regarding post-Norwood
physiology was the concept of pulmonary over-circulation and balancing the sys-
temic/pulmonary flow (Qp/Qs) ratio.5,7 Initial surgical response to increased under-
standing of this phenomenon included the use of smaller shunts, with a 3.5-mm
shunt being used for most infants and even a 3.0-mm shunt for those weighing less
than 3.0 kg.8 Despite a more favorable Qp/Qs ratio with the use of smaller shunts,
the fact that the shunt in a typical Norwood procedure comes off a systemic vessel
unavoidably results in diastolic runoff and lower diastolic pressure. In addition,
using a “one size fits all” approach can result in significant variation in saturations
and hemodynamics because of other variables such as size of the patient, size of the
feeding vessel, overall cardiac output, and pulmonary vascular resistance. Hence,
inadequate systemic perfusion as a result of increased Qp/Qs and significant cya-
nosis related to a decreased Qp/Qs are not uncommon in the early postoperative
period. The management of these patients can be quite complex and unfortunately
not always successful. In addition, concern has been raised regarding the effect of
the diastolic runoff in terms of both short-term and long-term coronary blood flow,
although no evidence exists that myocardial perfusion is significantly affected by the
classic shunt physiology. Nonetheless, the not infrequent progressive myocardial
failure seen in some patients after palliation for hypoplastic left heart syndrome
raises concern about coronary perfusion as a potential cause.
The importance of balancing shunt flow is so critical that placement of an
adjustable snare around the shunt9 or placement of hemaclips10 has been tried.
However, the potential risks of shunt thrombosis when snares are used, as well as
potential infectious issues from repeated mediastinal exploration for snare adjust-
ment, must be considered. Pulmonary blood flow can be limited by the use of a
3.0-mm polytetrafluoroethylene shunt (Gore-Tex; W. L. Gore & Associates, Inc,
Flagstaff, Ariz); however, it is generally believed that such shunts are at increased
risk of thrombosis and may require early reintervention as a result of worsening
cyanosis. Hence, management of Qp/Qs, and particularly over-circulation, has been
medical, with ventilator adjustment, use of systemic vasodilators, and support of
overall cardiac output being the mainstays of therapy.
Although the using a right ventricular–pulmonary artery (RV-PA) conduit rather
than a typical systemic–pulmonary artery shunt is one of the more recent and
intriguing modifications to the Norwood procedure, RV-PA conduits have been
described in place of classic systemic shunts in other congenital defects such as
pulmonary atresia with ventricular septal defect and pulmonary atresia with intact
ventricular septum. Although the first application of this technique to the Norwood
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operation is credited to Sano, the first publication including
this technique was by Imoto and colleagues11 from
Fukuoka, Japan. The first description of this technique at a
major national or international meeting is credited to
Sano,12 however. After these initial descriptions, the tech-
nique of the RV-PA conduit was quickly adopted by many
surgeons.13 However, due to the short time frame during
which this technique has been applied, long-term data are
lacking.
In this issue of the Journal, Mair and colleagues14 de-
scribe their experience with what is now generally referred
to as the “Sano” modification of the Norwood procedure.
The findings are intriguing despite certain limitations of the
study, such as a relatively small number of patients, short
follow-up, and the use of historical controls.
The authors report an overall Norwood experience of 32
patients with the last 14 undergoing the RV-PA conduit
modification. Although the in-house mortality was higher
among the patients undergoing the standard Norwood pro-
cedure, it is important to remember that this was not a
randomized study; in fact, the classic group represented the
authors’ earlier Norwood experience whereas the RV-PA
conduit group represented their more recent experience. It is
notable that a 3.5-mm shunt was used in all group 1 patients
despite the fact that 7 of the 18 patients weighed less than
3.0 kg. It is the practice of many to use a 3.0-mm shunt in
patients weighing less than 3.0 kg, which in theory would
result in a lower Qp/Qs in a manner similar to using an
RV-PA conduit. However, the authors make a very valid
point in that a smaller shunt is at increased risk of throm-
bosis, whereas presumably an RV-PA conduit, which is
actually larger, is less likely to thrombose; in either case
thrombosis is a rare occurrence.
Undoubtedly, the learning curve that all surgeons and
institutions experience with a complex operation such as a
Norwood procedure contributed to this mortality difference
as much as, if not more than, the technique used. Further-
more, on closer examination it appears that only 2 of the 5
early deaths in the earlier group were clearly cardiac related.
Nonetheless, based purely on subjective experience and
impressions from other centers reporting mortality rates of
around 30% with the standard approach, improved early
results have been seen with the RV-PA conduit modifica-
tion. However, centers such as ours, where mortality for
first-stage palliation of hypoplastic left heart syndrome is
under10% with the standard systemic-arterial shunt ap-
proach, have not seen a significant survival benefit nor an
appreciable difference in hemodynamic stability or postop-
erative course with the RV-PA modification. A plausible
explanation for the variation in results seen with this new
modification relates as much to shunt size and experience
with management of over-circulation as it does to the spe-
cific technique used.
Although improved early postoperative hemodynamics
has been attributed to this technique, little objective data
exist to support this. Mair and colleagues14 reported no
significant difference in use of inotropic agents, urine out-
put, or lactates in the early postoperative period between the
2 groups. Unfortunately, postoperative superior vena caval
saturations were not measured and Qp/Qs was not calcu-
lated. The patients with the RV-PA shunts did appear to
have lower overall pulmonary blood flow than those receiv-
ing the standard shunts, requiring higher inspired oxygen
fractions to maintain comparable arterial oxygen tensions.
Although based purely on operative outcome and early
hemodynamics there is little objective data supporting a
benefit to the RV-PA modification. More intriguing, and
perhaps compelling, data favoring this technique are dem-
onstrated by the pre-Glenn catheterization data. The statis-
tically significant finding of higher dP/dT in the RV-PA
conduit patients compared with the standard shunt approach
patients has potentially significant long-term implications.
Although once again taken in the context of a nonrandom-
ized, consecutive series, it appears that no other modifica-
tions in operative technique, bypass, or myocardial protec-
tion were altered between the 2 groups to account for this
difference. In a population of patients who are dependent on
maintaining good function of the systemic right ventricle,
improved systolic function in the RV-PA conduit group is
the best supporting evidence to date in support of this
technique. The authors imply that the improved dP/dT may
be a result of improved coronary perfusion as a result of
higher diastolic pressures, which they did demonstrate.
However, the effect of a higher diastolic pressure on coro-
nary perfusion in these patients is purely conjecture because
coronary perfusion was not measured and coronary blood
flow is largely controlled by complex autoregulation.
Mair and colleagues14 demonstrate that indeed an
RV-PA conduit can be used successfully and with good
early results; however, a significant early or late survival
advantage is not demonstrated. The improved dP/dT on
pre-Glenn catheterization is encouraging and may have im-
plications regarding long-term ventricular function and out-
come. However, this must be weighed against the potential
risks of placing a ventriculotomy in a patient with a single
ventricle. I congratulate the authors on their excellent results
and thank them for contributing to the experience and
understanding of this difficult group of patients and their
management.
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